{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T00:00:56Z","timestamp":1793664056460,"version":"4.5.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["amjmed.com","clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The American Journal of Medicine"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/j.amjmed.2019.10.023","type":"journal-article","created":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T23:04:53Z","timestamp":1573254293000},"page":"412-416","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Aspirin in the Treatment and Prevention of Migraine Headaches: Possible Additional Clinical Options for Primary Healthcare Providers"],"prefix":"10.1016","volume":"133","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-3779-4388","authenticated-orcid":false,"given":"Bianca","family":"Biglione","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Gitin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip B.","family":"Gorelick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-1214-1663","authenticated-orcid":false,"given":"Charles","family":"Hennekens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.amjmed.2019.10.023_bib0001","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/head.13281","article-title":"The prevalence and impact of migraine and severe headache in the United States: figures and trends from government health studies","volume":"58","author":"Burch","year":"2018","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.amjmed.2019.10.023_bib0002","first-page":"319","article-title":"Determinants of suboptimal migraine diagnosis and treatment in the primary care setting","volume":"24","author":"Kingston","year":"2017","journal-title":"J Clin Outcomes Manage"},{"issue":"5","key":"10.1016\/j.amjmed.2019.10.023_bib0003","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1212\/01.wnl.0000252808.97649.21","article-title":"Migraine prevalence, disease burden, and the need for preventive therapy","volume":"68","author":"Lipton","year":"2007","journal-title":"Neurology"},{"issue":"9","key":"10.1016\/j.amjmed.2019.10.023_bib0004","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1177\/0333102413485658","article-title":"The international classification of headache disorders, 3rd edition (beta version)","volume":"33","year":"2013","journal-title":"Cephalalgia"},{"issue":"4","key":"10.1016\/j.amjmed.2019.10.023_bib0005","doi-asserted-by":"crossref","first-page":"344","DOI":"10.7861\/clinmedicine.15-4-344","article-title":"Integrated care for chronic migraine patients: epidemiology, burden, diagnosis and treatment options","volume":"15","author":"Diener","year":"2015","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0006","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/head.13456","article-title":"The American Headache Society position statement on integrating new migraine treatments into clinical practice","volume":"59","year":"2019","journal-title":"Headache"},{"issue":"7","key":"10.1016\/j.amjmed.2019.10.023_bib0007","first-page":"663","article-title":"Acetylsalicylic acid effervescent 1000 mg (Aspirin) in acute migraine attacks; a multicentre, randomised, double-blind, single-dose, placebo-controlled parallel group study","volume":"20","author":"Lange","year":"2000","journal-title":"Cephalalgia"},{"issue":"11","key":"10.1016\/j.amjmed.2019.10.023_bib0008","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/j.1468-2982.2004.00783.x","article-title":"Placebo-controlled comparison of effervescent acetylsalicylic acid, sumatriptan and ibuprofen in the treatment of migraine attacks","volume":"24","author":"Diener","year":"2004","journal-title":"Cephalalgia"},{"issue":"1","key":"10.1016\/j.amjmed.2019.10.023_bib0009","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1159\/000079544","article-title":"Efficacy of 1,000 mg effervescent acetylsalicylic acid and sumatriptan in treating associated migraine symptoms","volume":"52","author":"Diener","year":"2004","journal-title":"Eur Neurol"},{"issue":"3","key":"10.1016\/j.amjmed.2019.10.023_bib0010","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1007\/s12471-014-0522-3","article-title":"Gastrointestinal symptoms in low-dose aspirin users: a comparison between plain and buffered aspirin","volume":"22","author":"Jaspers Focks","year":"2014","journal-title":"Neth Heart J"},{"issue":"3","key":"10.1016\/j.amjmed.2019.10.023_bib0011","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1159\/000116818","article-title":"A study to compare oral sumatriptan with oral aspirin plus oral metoclopramide in the acute treatment of migraine. The Oral Sumatriptan and Aspirin plus Metoclopramide Comparative Study Group","volume":"32","year":"1992","journal-title":"Eur Neurol"},{"issue":"4","key":"10.1016\/j.amjmed.2019.10.023_bib0012","article-title":"Aspirin with or without an antiemetic for acute migraine headaches in adults","author":"Kirthi","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0013","unstructured":"Food and Drug Administration. FDA requires boxed warning and risk mitigation strategy for metoclopramide-containing drugs [press release]. Available at:http:\/\/www.fda.gov\/bbs\/topics\/NEWS\/2009\/NEW01963.html. Accessed October 8, 2019."},{"issue":"3","key":"10.1016\/j.amjmed.2019.10.023_bib0014","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1586\/14779072.2014.873700","article-title":"Cardiovascular risks of non-steroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors: necessary but not sufficient for clinical decision making","volume":"12","author":"Hennekens","year":"2014","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0015","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2165\/00002018-200326020-00003","article-title":"Tolerability of the triptans: clinical implications","volume":"26","author":"Nappi","year":"2003","journal-title":"Drug Saf"},{"issue":"2","key":"10.1016\/j.amjmed.2019.10.023_bib0016","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1046\/j.1468-2982.2001.00168.x","article-title":"A comparative study of oral acetylsalicyclic acid and metoprolol for the prophylactic treatment of migraine. A randomized, controlled, double-blind, parallel group phase III study","volume":"21","author":"Diener","year":"2001","journal-title":"Cephalalgia"},{"issue":"6","key":"10.1016\/j.amjmed.2019.10.023_bib0017","article-title":"Topiramate for the prophylaxis of episodic migraine in adults","author":"Linde","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0018","article-title":"Botulinum toxins for the prevention of migraine in adults","volume":"6","author":"Herd","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0019","doi-asserted-by":"crossref","first-page":"k2228","DOI":"10.1136\/bmj.k2228","article-title":"US approves first monoclonal antibody to prevent migraines","volume":"361","author":"Dyer","year":"2018","journal-title":"BMJ"},{"issue":"6","key":"10.1016\/j.amjmed.2019.10.023_bib0020","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1007\/s00415-018-8886-8","article-title":"Monoclonal antibodies for migraine: an update","author":"Castle","year":"2018","journal-title":"J Neurol"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0021","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1056\/NEJM198801283180431","article-title":"Preliminary report: findings from the aspirin component of the ongoing Physicians\u2019 Health Study","volume":"318","year":"1988","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0022","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJM198907203210301","article-title":"Final report on the aspirin component of the ongoing Physicians\u2019 Health Study","volume":"321","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0023","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1136\/bmj.296.6618.313","article-title":"A randomised trial of of prophylactic daily aspirin in British male doctors","volume":"296","author":"Peto","year":"1988","journal-title":"Br Med J (Clin Res Ed)"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0024","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1001\/jama.1990.03450130083031","article-title":"Low-dose aspirin for migraine prophylaxis","volume":"264","author":"Buring","year":"1990","journal-title":"JAMA"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0025","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1056\/NEJMoa050613","article-title":"A randomized trial of low-dose aspirin in the primary prevention of cardiovascular disease in women","volume":"352","author":"Ridker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0026","doi-asserted-by":"crossref","first-page":"b3914","DOI":"10.1136\/bmj.b3914","article-title":"Migraine and cardiovascular disease: systematic review and meta-analysis","volume":"339","author":"Sch\u00fcrks","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0027","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1001\/archneur.1995.00540260031012","article-title":"Migraine and subsequent risk of stroke in the Physicians\u2019 Health Study","volume":"52","author":"Buring","year":"1995","journal-title":"Arch Neurol"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0028","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1046\/j.0333-1024.2001.00194.x","article-title":"Low-dose aspirin for migraine prophlaxis in women","volume":"21","author":"Bense\u00f1or","year":"2001","journal-title":"Cephalalgia"},{"key":"10.1016\/j.amjmed.2019.10.023_bib0029","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1590\/1516-3180.2016.0165050916","article-title":"The effectiveness of aspirin for migraine prophylaxis: a systematic review","volume":"135","author":"Baena","year":"2017","journal-title":"Sao Paulo Med J"}],"container-title":["The American Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319309660?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0002934319309660?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T09:18:28Z","timestamp":1757582308000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0002934319309660"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,4]]},"references-count":29,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S0002934319309660"],"URL":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.10.023","relation":{},"ISSN":["0002-9343"],"issn-type":[{"value":"0002-9343","type":"print"}],"subject":[],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aspirin in the Treatment and Prevention of Migraine Headaches: Possible Additional Clinical Options for Primary Healthcare Providers","name":"articletitle","label":"Article Title"},{"value":"The American Journal of Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.10.023","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.amjmed.2019.11.002","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}